vs

Side-by-side financial comparison of Dolby Laboratories, Inc. (DLB) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.

Dolby Laboratories, Inc. is the larger business by last-quarter revenue ($395.6M vs $213.6M, roughly 1.9× Vital Farms, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs 7.6%, a 16.3% gap on every dollar of revenue. On growth, Vital Farms, Inc. posted the faster year-over-year revenue change (28.7% vs 7.1%). Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 13.9%).

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".

DLB vs VITL — Head-to-Head

Bigger by revenue
DLB
DLB
1.9× larger
DLB
$395.6M
$213.6M
VITL
Growing faster (revenue YoY)
VITL
VITL
+21.6% gap
VITL
28.7%
7.1%
DLB
Higher net margin
DLB
DLB
16.3% more per $
DLB
24.0%
7.6%
VITL
Faster 2-yr revenue CAGR
VITL
VITL
Annualised
VITL
20.2%
13.9%
DLB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DLB
DLB
VITL
VITL
Revenue
$395.6M
$213.6M
Net Profit
$94.9M
$16.3M
Gross Margin
88.7%
35.8%
Operating Margin
28.5%
10.0%
Net Margin
24.0%
7.6%
Revenue YoY
7.1%
28.7%
Net Profit YoY
3.4%
54.3%
EPS (diluted)
$0.99
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLB
DLB
VITL
VITL
Q2 26
$395.6M
Q1 26
$346.7M
Q4 25
$346.7M
$213.6M
Q3 25
$307.0M
$198.9M
Q2 25
$315.5M
$184.8M
Q1 25
$369.6M
$162.2M
Q4 24
$357.0M
$166.0M
Q3 24
$304.8M
$145.0M
Net Profit
DLB
DLB
VITL
VITL
Q2 26
$94.9M
Q1 26
$53.3M
Q4 25
$53.3M
$16.3M
Q3 25
$49.3M
$16.4M
Q2 25
$46.1M
$16.6M
Q1 25
$91.8M
$16.9M
Q4 24
$67.8M
$10.6M
Q3 24
$58.6M
$7.4M
Gross Margin
DLB
DLB
VITL
VITL
Q2 26
88.7%
Q1 26
87.5%
Q4 25
87.5%
35.8%
Q3 25
87.1%
37.7%
Q2 25
86.1%
38.9%
Q1 25
90.3%
38.5%
Q4 24
88.6%
36.1%
Q3 24
88.8%
36.9%
Operating Margin
DLB
DLB
VITL
VITL
Q2 26
28.5%
Q1 26
17.9%
Q4 25
17.9%
10.0%
Q3 25
9.7%
10.8%
Q2 25
15.1%
12.9%
Q1 25
29.2%
13.4%
Q4 24
22.4%
7.8%
Q3 24
15.2%
6.4%
Net Margin
DLB
DLB
VITL
VITL
Q2 26
24.0%
Q1 26
15.4%
Q4 25
15.4%
7.6%
Q3 25
16.1%
8.3%
Q2 25
14.6%
9.0%
Q1 25
24.8%
10.4%
Q4 24
19.0%
6.4%
Q3 24
19.2%
5.1%
EPS (diluted)
DLB
DLB
VITL
VITL
Q2 26
$0.99
Q1 26
$0.55
Q4 25
$0.55
$0.35
Q3 25
$0.50
$0.36
Q2 25
$0.48
$0.36
Q1 25
$0.94
$0.37
Q4 24
$0.70
$0.23
Q3 24
$0.59
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLB
DLB
VITL
VITL
Cash + ST InvestmentsLiquidity on hand
$594.7M
$48.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$351.3M
Total Assets
$3.2B
$518.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLB
DLB
VITL
VITL
Q2 26
$594.7M
Q1 26
$644.6M
Q4 25
$644.6M
$48.8M
Q3 25
$702.6M
$93.8M
Q2 25
$699.3M
$108.2M
Q1 25
$626.6M
$156.3M
Q4 24
$520.8M
$150.6M
Q3 24
$482.0M
$149.5M
Stockholders' Equity
DLB
DLB
VITL
VITL
Q2 26
$2.6B
Q1 26
$2.6B
Q4 25
$2.6B
$351.3M
Q3 25
$2.6B
$331.2M
Q2 25
$2.6B
$309.8M
Q1 25
$2.6B
$288.9M
Q4 24
$2.5B
$269.3M
Q3 24
$2.5B
$253.4M
Total Assets
DLB
DLB
VITL
VITL
Q2 26
$3.2B
Q1 26
$3.2B
Q4 25
$3.2B
$518.7M
Q3 25
$3.2B
$481.5M
Q2 25
$3.2B
$430.8M
Q1 25
$3.2B
$376.9M
Q4 24
$3.2B
$359.3M
Q3 24
$3.1B
$344.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLB
DLB
VITL
VITL
Operating Cash FlowLast quarter
$147.3M
$5.8M
Free Cash FlowOCF − Capex
$-32.1M
FCF MarginFCF / Revenue
-15.1%
Capex IntensityCapex / Revenue
17.8%
Cash ConversionOCF / Net Profit
1.55×
0.35×
TTM Free Cash FlowTrailing 4 quarters
$-48.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLB
DLB
VITL
VITL
Q2 26
$147.3M
Q1 26
$54.8M
Q4 25
$54.8M
$5.8M
Q3 25
$472.2M
$23.4M
Q2 25
$67.7M
$-761.0K
Q1 25
$174.9M
$5.3M
Q4 24
$106.8M
$14.8M
Q3 24
$327.3M
$10.0M
Free Cash Flow
DLB
DLB
VITL
VITL
Q2 26
Q1 26
Q4 25
$50.2M
$-32.1M
Q3 25
$435.9M
$-10.6M
Q2 25
$61.3M
$-7.6M
Q1 25
$168.0M
$2.1M
Q4 24
$100.0M
$-3.4M
Q3 24
$297.2M
$6.4M
FCF Margin
DLB
DLB
VITL
VITL
Q2 26
Q1 26
Q4 25
14.5%
-15.1%
Q3 25
142.0%
-5.3%
Q2 25
19.4%
-4.1%
Q1 25
45.5%
1.3%
Q4 24
28.0%
-2.0%
Q3 24
97.5%
4.4%
Capex Intensity
DLB
DLB
VITL
VITL
Q2 26
Q1 26
Q4 25
1.3%
17.8%
Q3 25
11.8%
17.1%
Q2 25
2.0%
3.7%
Q1 25
1.9%
1.9%
Q4 24
1.9%
10.9%
Q3 24
9.8%
2.5%
Cash Conversion
DLB
DLB
VITL
VITL
Q2 26
1.55×
Q1 26
1.03×
Q4 25
1.03×
0.35×
Q3 25
9.57×
1.43×
Q2 25
1.47×
-0.05×
Q1 25
1.91×
0.31×
Q4 24
1.57×
1.40×
Q3 24
5.59×
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLB
DLB

Licensing$372.2M94%
Products and services$23.4M6%

VITL
VITL

Eggs And Egg Related Products$205.8M96%
Butter And Butter Related Products$7.7M4%

Related Comparisons